APO Research
Talk to an analyst

APO RESEARCH · REPORT

Free Circulating Tumor Cell Detection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Free Circulating Tumor Cell Detection Industry Growth and Trends Forecast to 2032

26 December 202592 pages

Choose your research edition.

Industry ResearchFree Circulating Tumor Cell Detection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Free Circulating Tumor Cell Detection Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Free Circulating Tumor Cell Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Free Circulating Tumor Cell Detection Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Free Circulating Tumor Cell Detection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Free Circulating Tumor Cell Detection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Free Circulating Tumor Cell Detection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Free Circulating Tumor Cell Detection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Free Circulating Tumor Cell Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Free Circulating Tumor Cell Detection include Thermo Fisher Scientific, F. Hoffmann-La Roche AG, Qiagen, Sysmex Europe SE, Rarecyte, Fluxion Biosciences Inc., Bio-Rad Laboratories Inc., Biocept Inc. and ANGLE plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Free Circulating Tumor Cell Detection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Free Circulating Tumor Cell Detection market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Free Circulating Tumor Cell Detection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Free Circulating Tumor Cell Detection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Free Circulating Tumor Cell Detection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Free Circulating Tumor Cell Detection Market by Company

Thermo Fisher Scientific

F. Hoffmann-La Roche AG

Qiagen

Sysmex Europe SE

Rarecyte

Fluxion Biosciences Inc.

Bio-Rad Laboratories Inc.

Biocept Inc.

ANGLE plc

Free Circulating Tumor Cell Detection Segment by Type

RNA Detection

Protein Marker Detection

Gene Marker Detection

Free Circulating Tumor Cell Detection Segment by Application

Hospital

Physical Examination Center

Free Circulating Tumor Cell Detection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Free Circulating Tumor Cell Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Free Circulating Tumor Cell Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Free Circulating Tumor Cell Detection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Free Circulating Tumor Cell Detection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Free Circulating Tumor Cell Detection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of RNA Detection Table 2. Major Company of Protein Marker Detection Table 3. Major Company of Gene Marker Detection Table 4. Global Free Circulating Tumor Cell Detection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Free Circulating Tumor Cell Detection Sales by Type (2021-2026) & (Units) Table 6. Global Free Circulating Tumor Cell Detection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Free Circulating Tumor Cell Detection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Free Circulating Tumor Cell Detection Sales Market Share in Value by Type (2021-2026) Table 9. Global Free Circulating Tumor Cell Detection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Free Circulating Tumor Cell Detection Sales by Type (2027-2032) & (Units) Table 11. Global Free Circulating Tumor Cell Detection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Free Circulating Tumor Cell Detection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Free Circulating Tumor Cell Detection Sales Market Share in Value by Type (2027-2032) Table 14. Global Free Circulating Tumor Cell Detection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Free Circulating Tumor Cell Detection Sales by Type (2021-2026) & (Units) Table 16. North America Free Circulating Tumor Cell Detection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Free Circulating Tumor Cell Detection Sales by Type (2021-2026) & (Units) Table 18. Europe Free Circulating Tumor Cell Detection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Free Circulating Tumor Cell Detection Sales by Type (2021-2026) & (Units) Table 20. Asia-Pacific Free Circulating Tumor Cell Detection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Free Circulating Tumor Cell Detection Sales by Type (2021-2026) & (Units) Table 22. Latin America Free Circulating Tumor Cell Detection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Free Circulating Tumor Cell Detection Sales by Type (2021-2026) & (Units) Table 24. Middle East and Africa Free Circulating Tumor Cell Detection Sales by Type (2021-2026) & (US$ Million) Table 25. Free Circulating Tumor Cell Detection Industry Trends Table 26. Free Circulating Tumor Cell Detection Industry Drivers Table 27. Free Circulating Tumor Cell Detection Industry Opportunities and Challenges Table 28. Free Circulating Tumor Cell Detection Industry Restraints Table 29. Global Free Circulating Tumor Cell Detection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Free Circulating Tumor Cell Detection Revenue Market Share by Company (2021-2026) Table 31. Global Free Circulating Tumor Cell Detection Sales by Company (2021-2026) & (Units) Table 32. Global Free Circulating Tumor Cell Detection Sales Share by Company (2021-2026) Table 33. Global Free Circulating Tumor Cell Detection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Free Circulating Tumor Cell Detection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Free Circulating Tumor Cell Detection Major Company Production Sites and Headquarters Table 36. Global Free Circulating Tumor Cell Detection Company, Product Type & Application Table 37. Global Free Circulating Tumor Cell Detection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Free Circulating Tumor Cell Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Free Circulating Tumor Cell Detection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Free Circulating Tumor Cell Detection Sales by Region (2021-2026) & (Units) Table 42. Global Free Circulating Tumor Cell Detection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Free Circulating Tumor Cell Detection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Free Circulating Tumor Cell Detection Sales Market Share in Value by Region (2021-2026) Table 45. Global Free Circulating Tumor Cell Detection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Free Circulating Tumor Cell Detection Sales by Region (2027-2032) & (Units) Table 47. Global Free Circulating Tumor Cell Detection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Free Circulating Tumor Cell Detection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Free Circulating Tumor Cell Detection Sales Market Share in Value by Region (2027-2032) Table 50. Global Free Circulating Tumor Cell Detection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Free Circulating Tumor Cell Detection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Free Circulating Tumor Cell Detection Sales by Application (2021-2026) & (Units) Table 53. Global Free Circulating Tumor Cell Detection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Free Circulating Tumor Cell Detection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Free Circulating Tumor Cell Detection Sales Market Share in Value by Application (2021-2026) Table 56. Global Free Circulating Tumor Cell Detection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Free Circulating Tumor Cell Detection Sales by Application (2027-2032) & (Units) Table 58. Global Free Circulating Tumor Cell Detection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Free Circulating Tumor Cell Detection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Free Circulating Tumor Cell Detection Sales Market Share in Value by Application (2027-2032) Table 61. Global Free Circulating Tumor Cell Detection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Free Circulating Tumor Cell Detection Sales by Application (2021-2026) & (Units) Table 63. North America Free Circulating Tumor Cell Detection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Free Circulating Tumor Cell Detection Sales by Application (2021-2026) & (Units) Table 65. Europe Free Circulating Tumor Cell Detection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Free Circulating Tumor Cell Detection Sales by Application (2021-2026) & (Units) Table 67. Asia-Pacific Free Circulating Tumor Cell Detection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Free Circulating Tumor Cell Detection Sales by Application (2021-2026) & (Units) Table 69. Latin America Free Circulating Tumor Cell Detection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Free Circulating Tumor Cell Detection Sales by Application (2021-2026) & (Units) Table 71. Middle East and Africa Free Circulating Tumor Cell Detection Sales by Application (2021-2026) & (US$ Million) Table 72. Thermo Fisher Scientific Company Information Table 73. Thermo Fisher Scientific Business Overview Table 74. Thermo Fisher Scientific Free Circulating Tumor Cell Detection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Thermo Fisher Scientific Free Circulating Tumor Cell Detection Product Portfolio Table 76. Thermo Fisher Scientific Recent Development Table 77. F. Hoffmann-La Roche AG Company Information Table 78. F. Hoffmann-La Roche AG Business Overview Table 79. F. Hoffmann-La Roche AG Free Circulating Tumor Cell Detection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. F. Hoffmann-La Roche AG Free Circulating Tumor Cell Detection Product Portfolio Table 81. F. Hoffmann-La Roche AG Recent Development Table 82. Qiagen Company Information Table 83. Qiagen Business Overview Table 84. Qiagen Free Circulating Tumor Cell Detection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Qiagen Free Circulating Tumor Cell Detection Product Portfolio Table 86. Qiagen Recent Development Table 87. Sysmex Europe SE Company Information Table 88. Sysmex Europe SE Business Overview Table 89. Sysmex Europe SE Free Circulating Tumor Cell Detection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sysmex Europe SE Free Circulating Tumor Cell Detection Product Portfolio Table 91. Sysmex Europe SE Recent Development Table 92. Rarecyte Company Information Table 93. Rarecyte Business Overview Table 94. Rarecyte Free Circulating Tumor Cell Detection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Rarecyte Free Circulating Tumor Cell Detection Product Portfolio Table 96. Rarecyte Recent Development Table 97. Fluxion Biosciences Inc. Company Information Table 98. Fluxion Biosciences Inc. Business Overview Table 99. Fluxion Biosciences Inc. Free Circulating Tumor Cell Detection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Fluxion Biosciences Inc. Free Circulating Tumor Cell Detection Product Portfolio Table 101. Fluxion Biosciences Inc. Recent Development Table 102. Bio-Rad Laboratories Inc. Company Information Table 103. Bio-Rad Laboratories Inc. Business Overview Table 104. Bio-Rad Laboratories Inc. Free Circulating Tumor Cell Detection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Bio-Rad Laboratories Inc. Free Circulating Tumor Cell Detection Product Portfolio Table 106. Bio-Rad Laboratories Inc. Recent Development Table 107. Biocept Inc. Company Information Table 108. Biocept Inc. Business Overview Table 109. Biocept Inc. Free Circulating Tumor Cell Detection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Biocept Inc. Free Circulating Tumor Cell Detection Product Portfolio Table 111. Biocept Inc. Recent Development Table 112. ANGLE plc Company Information Table 113. ANGLE plc Business Overview Table 114. ANGLE plc Free Circulating Tumor Cell Detection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. ANGLE plc Free Circulating Tumor Cell Detection Product Portfolio Table 116. ANGLE plc Recent Development Table 117. North America Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 118. North America Free Circulating Tumor Cell Detection Sales by Country (2021-2026) & (Units) Table 119. North America Free Circulating Tumor Cell Detection Sales Market Share by Country (2021-2026) Table 120. North America Free Circulating Tumor Cell Detection Sales Forecast by Country (2027-2032) & (Units) Table 121. North America Free Circulating Tumor Cell Detection Sales Market Share Forecast by Country (2027-2032) Table 122. North America Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Free Circulating Tumor Cell Detection Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Free Circulating Tumor Cell Detection Market Share by Country (2021-2026) Table 125. North America Free Circulating Tumor Cell Detection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Free Circulating Tumor Cell Detection Market Share Forecast by Country (2027-2032) Table 127. Europe Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 128. Europe Free Circulating Tumor Cell Detection Sales by Country (2021-2026) & (Units) Table 129. Europe Free Circulating Tumor Cell Detection Sales Market Share by Country (2021-2026) Table 130. Europe Free Circulating Tumor Cell Detection Sales Forecast by Country (2027-2032) & (Units) Table 131. Europe Free Circulating Tumor Cell Detection Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Free Circulating Tumor Cell Detection Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Free Circulating Tumor Cell Detection Market Share by Country (2021-2026) Table 135. Europe Free Circulating Tumor Cell Detection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Free Circulating Tumor Cell Detection Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Free Circulating Tumor Cell Detection Sales by Country (2021-2026) & (Units) Table 139. Asia-Pacific Free Circulating Tumor Cell Detection Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Free Circulating Tumor Cell Detection Sales Forecast by Country (2027-2032) & (Units) Table 141. Asia-Pacific Free Circulating Tumor Cell Detection Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Free Circulating Tumor Cell Detection Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Free Circulating Tumor Cell Detection Market Share by Country (2021-2026) Table 145. Asia-Pacific Free Circulating Tumor Cell Detection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Free Circulating Tumor Cell Detection Market Share Forecast by Country (2027-2032) Table 147. Latin America Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 148. Latin America Free Circulating Tumor Cell Detection Sales by Country (2021-2026) & (Units) Table 149. Latin America Free Circulating Tumor Cell Detection Sales Market Share by Country (2021-2026) Table 150. Latin America Free Circulating Tumor Cell Detection Sales Forecast by Country (2027-2032) & (Units) Table 151. Latin America Free Circulating Tumor Cell Detection Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Free Circulating Tumor Cell Detection Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Free Circulating Tumor Cell Detection Market Share by Country (2021-2026) Table 155. Latin America Free Circulating Tumor Cell Detection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Free Circulating Tumor Cell Detection Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Free Circulating Tumor Cell Detection Sales by Country (2021-2026) & (Units) Table 159. Middle East and Africa Free Circulating Tumor Cell Detection Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Free Circulating Tumor Cell Detection Sales Forecast by Country (2027-2032) & (Units) Table 161. Middle East and Africa Free Circulating Tumor Cell Detection Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Free Circulating Tumor Cell Detection Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Free Circulating Tumor Cell Detection Market Share by Country (2021-2026) Table 165. Middle East and Africa Free Circulating Tumor Cell Detection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Free Circulating Tumor Cell Detection Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Free Circulating Tumor Cell Detection Distributors List Table 170. Free Circulating Tumor Cell Detection Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Free Circulating Tumor Cell Detection Image Figure 2. Global Free Circulating Tumor Cell Detection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Free Circulating Tumor Cell Detection Market Size (2021-2032) & (US$ Million) Figure 4. Global Free Circulating Tumor Cell Detection Sales (2021-2032) & (Units) Figure 5. RNA Detection Image Figure 6. Global RNA Detection Sales YoY Growth (2021-2032) & (Units) Figure 7. Protein Marker Detection Image Figure 8. Global Protein Marker Detection Sales YoY Growth (2021-2032) & (Units) Figure 9. Gene Marker Detection Image Figure 10. Global Gene Marker Detection Sales YoY Growth (2021-2032) & (Units) Figure 11. Global Free Circulating Tumor Cell Detection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Free Circulating Tumor Cell Detection Market Share by Type 2025 VS 2032 Figure 13. North America Free Circulating Tumor Cell Detection Sales Market Share in Volume by Type in 2025 Figure 14. North America Free Circulating Tumor Cell Detection Sales Market Share in Value by Type in 2025 Figure 15. Europe Free Circulating Tumor Cell Detection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Free Circulating Tumor Cell Detection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Free Circulating Tumor Cell Detection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Free Circulating Tumor Cell Detection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Free Circulating Tumor Cell Detection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Free Circulating Tumor Cell Detection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Free Circulating Tumor Cell Detection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Free Circulating Tumor Cell Detection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Free Circulating Tumor Cell Detection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (Units) Figure 27. Physical Examination Center Image Figure 28. Global Physical Examination Center Sales YoY Growth (2021-2032) & (Units) Figure 29. Global Free Circulating Tumor Cell Detection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Free Circulating Tumor Cell Detection Market Share by Application 2025 VS 2032 Figure 31. North America Free Circulating Tumor Cell Detection Sales Market Share in Volume by Application in 2025 Figure 32. North America Free Circulating Tumor Cell Detection Sales Market Share in Value by Application in 2025 Figure 33. Europe Free Circulating Tumor Cell Detection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Free Circulating Tumor Cell Detection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Free Circulating Tumor Cell Detection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Free Circulating Tumor Cell Detection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Free Circulating Tumor Cell Detection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Free Circulating Tumor Cell Detection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Free Circulating Tumor Cell Detection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Free Circulating Tumor Cell Detection Sales Market Share in Value by Application in 2025 Figure 41. North America Free Circulating Tumor Cell Detection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 42. North America Free Circulating Tumor Cell Detection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Free Circulating Tumor Cell Detection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Free Circulating Tumor Cell Detection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Free Circulating Tumor Cell Detection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 46. Europe Free Circulating Tumor Cell Detection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Free Circulating Tumor Cell Detection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Free Circulating Tumor Cell Detection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Free Circulating Tumor Cell Detection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. Asia-Pacific Free Circulating Tumor Cell Detection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Free Circulating Tumor Cell Detection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Free Circulating Tumor Cell Detection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Free Circulating Tumor Cell Detection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Latin America Free Circulating Tumor Cell Detection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Free Circulating Tumor Cell Detection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Free Circulating Tumor Cell Detection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Free Circulating Tumor Cell Detection Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Middle East and Africa Free Circulating Tumor Cell Detection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Free Circulating Tumor Cell Detection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Free Circulating Tumor Cell Detection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Free Circulating Tumor Cell Detection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Free Circulating Tumor Cell Detection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • RNA Detection
  • Protein Marker Detection
  • Gene Marker Detection
Applications
  • Hospital
  • Physical Examination Center
Companies covered
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche AG
  • Qiagen
  • Sysmex Europe SE
  • Rarecyte
  • Fluxion Biosciences Inc.
  • Bio-Rad Laboratories Inc.
  • Biocept Inc.
  • ANGLE plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Free Circulating Tumor Cell Detection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Free Circulating Tumor Cell Detection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Free Circulating Tumor Cell Detection Market by Type
  6. 1.3.1 RNA Detection
  7. 1.3.2 Protein Marker Detection
  8. 1.3.3 Gene Marker Detection
  9. 1.4 Global Free Circulating Tumor Cell Detection Market Size by Type
  10. 1.4.1 Global Free Circulating Tumor Cell Detection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Free Circulating Tumor Cell Detection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Free Circulating Tumor Cell Detection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Free Circulating Tumor Cell Detection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Free Circulating Tumor Cell Detection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Free Circulating Tumor Cell Detection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Free Circulating Tumor Cell Detection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Free Circulating Tumor Cell Detection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Free Circulating Tumor Cell Detection Industry Trends
  2. 2.2 Free Circulating Tumor Cell Detection Industry Drivers
  3. 2.3 Free Circulating Tumor Cell Detection Industry Opportunities and Challenges
  4. 2.4 Free Circulating Tumor Cell Detection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Free Circulating Tumor Cell Detection Revenue (2021-2026)
  2. 3.2 Global Top Players by Free Circulating Tumor Cell Detection Sales (2021-2026)
  3. 3.3 Global Top Players by Free Circulating Tumor Cell Detection Price (2021-2026)
  4. 3.4 Global Free Circulating Tumor Cell Detection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Free Circulating Tumor Cell Detection Major Company Production Sites & Headquarters
  6. 3.6 Global Free Circulating Tumor Cell Detection Company, Product Type & Application
  7. 3.7 Global Free Circulating Tumor Cell Detection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Free Circulating Tumor Cell Detection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Free Circulating Tumor Cell Detection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Free Circulating Tumor Cell Detection Tier 1, Tier 2, and Tier 3
4 Free Circulating Tumor Cell Detection Regional Status and Outlook
  1. 4.1 Global Free Circulating Tumor Cell Detection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Free Circulating Tumor Cell Detection Historic Market Size by Region
  3. 4.2.1 Global Free Circulating Tumor Cell Detection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Free Circulating Tumor Cell Detection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Free Circulating Tumor Cell Detection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Free Circulating Tumor Cell Detection Forecasted Market Size by Region
  7. 4.3.1 Global Free Circulating Tumor Cell Detection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Free Circulating Tumor Cell Detection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Free Circulating Tumor Cell Detection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Free Circulating Tumor Cell Detection by Application
  1. 5.1 Free Circulating Tumor Cell Detection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Physical Examination Center
  4. 5.2 Global Free Circulating Tumor Cell Detection Market Size by Application
  5. 5.2.1 Global Free Circulating Tumor Cell Detection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Free Circulating Tumor Cell Detection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Free Circulating Tumor Cell Detection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Free Circulating Tumor Cell Detection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Free Circulating Tumor Cell Detection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Free Circulating Tumor Cell Detection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Free Circulating Tumor Cell Detection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Free Circulating Tumor Cell Detection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Free Circulating Tumor Cell Detection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Free Circulating Tumor Cell Detection Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 F. Hoffmann-La Roche AG
  8. 6.2.1 F. Hoffmann-La Roche AG Company Information
  9. 6.2.2 F. Hoffmann-La Roche AG Business Overview
  10. 6.2.3 F. Hoffmann-La Roche AG Free Circulating Tumor Cell Detection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 F. Hoffmann-La Roche AG Free Circulating Tumor Cell Detection Product Portfolio
  12. 6.2.5 F. Hoffmann-La Roche AG Recent Developments
  13. 6.3 Qiagen
  14. 6.3.1 Qiagen Company Information
  15. 6.3.2 Qiagen Business Overview
  16. 6.3.3 Qiagen Free Circulating Tumor Cell Detection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qiagen Free Circulating Tumor Cell Detection Product Portfolio
  18. 6.3.5 Qiagen Recent Developments
  19. 6.4 Sysmex Europe SE
  20. 6.4.1 Sysmex Europe SE Company Information
  21. 6.4.2 Sysmex Europe SE Business Overview
  22. 6.4.3 Sysmex Europe SE Free Circulating Tumor Cell Detection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sysmex Europe SE Free Circulating Tumor Cell Detection Product Portfolio
  24. 6.4.5 Sysmex Europe SE Recent Developments
  25. 6.5 Rarecyte
  26. 6.5.1 Rarecyte Company Information
  27. 6.5.2 Rarecyte Business Overview
  28. 6.5.3 Rarecyte Free Circulating Tumor Cell Detection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Rarecyte Free Circulating Tumor Cell Detection Product Portfolio
  30. 6.5.5 Rarecyte Recent Developments
  31. 6.6 Fluxion Biosciences Inc.
  32. 6.6.1 Fluxion Biosciences Inc. Company Information
  33. 6.6.2 Fluxion Biosciences Inc. Business Overview
  34. 6.6.3 Fluxion Biosciences Inc. Free Circulating Tumor Cell Detection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fluxion Biosciences Inc. Free Circulating Tumor Cell Detection Product Portfolio
  36. 6.6.5 Fluxion Biosciences Inc. Recent Developments
  37. 6.7 Bio-Rad Laboratories Inc.
  38. 6.7.1 Bio-Rad Laboratories Inc. Company Information
  39. 6.7.2 Bio-Rad Laboratories Inc. Business Overview
  40. 6.7.3 Bio-Rad Laboratories Inc. Free Circulating Tumor Cell Detection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bio-Rad Laboratories Inc. Free Circulating Tumor Cell Detection Product Portfolio
  42. 6.7.5 Bio-Rad Laboratories Inc. Recent Developments
  43. 6.8 Biocept Inc.
  44. 6.8.1 Biocept Inc. Company Information
  45. 6.8.2 Biocept Inc. Business Overview
  46. 6.8.3 Biocept Inc. Free Circulating Tumor Cell Detection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biocept Inc. Free Circulating Tumor Cell Detection Product Portfolio
  48. 6.8.5 Biocept Inc. Recent Developments
  49. 6.9 ANGLE plc
  50. 6.9.1 ANGLE plc Company Information
  51. 6.9.2 ANGLE plc Business Overview
  52. 6.9.3 ANGLE plc Free Circulating Tumor Cell Detection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 ANGLE plc Free Circulating Tumor Cell Detection Product Portfolio
  54. 6.9.5 ANGLE plc Recent Developments
7 North America by Country
  1. 7.1 North America Free Circulating Tumor Cell Detection Sales by Country
  2. 7.1.1 North America Free Circulating Tumor Cell Detection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Free Circulating Tumor Cell Detection Sales by Country (2021-2026)
  4. 7.1.3 North America Free Circulating Tumor Cell Detection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Free Circulating Tumor Cell Detection Market Size by Country
  6. 7.2.1 North America Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Free Circulating Tumor Cell Detection Market Size by Country (2021-2026)
  8. 7.2.3 North America Free Circulating Tumor Cell Detection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Free Circulating Tumor Cell Detection Sales by Country
  2. 8.1.1 Europe Free Circulating Tumor Cell Detection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Free Circulating Tumor Cell Detection Sales by Country (2021-2026)
  4. 8.1.3 Europe Free Circulating Tumor Cell Detection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Free Circulating Tumor Cell Detection Market Size by Country
  6. 8.2.1 Europe Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Free Circulating Tumor Cell Detection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Free Circulating Tumor Cell Detection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Free Circulating Tumor Cell Detection Sales by Country
  2. 9.1.1 Asia-Pacific Free Circulating Tumor Cell Detection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Free Circulating Tumor Cell Detection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Free Circulating Tumor Cell Detection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Free Circulating Tumor Cell Detection Market Size by Country
  6. 9.2.1 Asia-Pacific Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Free Circulating Tumor Cell Detection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Free Circulating Tumor Cell Detection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Free Circulating Tumor Cell Detection Sales by Country
  2. 10.1.1 South America Free Circulating Tumor Cell Detection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Free Circulating Tumor Cell Detection Sales by Country (2021-2026)
  4. 10.1.3 South America Free Circulating Tumor Cell Detection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Free Circulating Tumor Cell Detection Market Size by Country
  6. 10.2.1 South America Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Free Circulating Tumor Cell Detection Market Size by Country (2021-2026)
  8. 10.2.3 South America Free Circulating Tumor Cell Detection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Free Circulating Tumor Cell Detection Sales by Country
  2. 11.1.1 Middle East and Africa Free Circulating Tumor Cell Detection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Free Circulating Tumor Cell Detection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Free Circulating Tumor Cell Detection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Free Circulating Tumor Cell Detection Market Size by Country
  6. 11.2.1 Middle East and Africa Free Circulating Tumor Cell Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Free Circulating Tumor Cell Detection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Free Circulating Tumor Cell Detection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Free Circulating Tumor Cell Detection Value Chain Analysis
  2. 12.1.1 Free Circulating Tumor Cell Detection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Free Circulating Tumor Cell Detection Production Mode & Process
  7. 12.2 Free Circulating Tumor Cell Detection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Free Circulating Tumor Cell Detection Distributors
  10. 12.2.3 Free Circulating Tumor Cell Detection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst